Contacare Opthalmic Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.50 M
as on 03-07-2024
- Company Age 27 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 50.00 Cr
as on 03-07-2024
- Revenue -59.52%
(FY 2023)
- Profit 52.49%
(FY 2023)
- Ebitda 60.39%
(FY 2023)
- Net Worth -6.12%
(FY 2023)
- Total Assets -60.49%
(FY 2023)
About Contacare Opthalmic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹50.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jagrat Dave and Purnima Dave serve as directors at the Company.
- CIN/LLPIN
U24230MH1997PTC108029
- Company No.
108029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 1997
- Date of AGM
01 Feb 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Dadar West, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Contacare Opthalmic Private Limited offer?
Contacare Opthalmic Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Contact Lenses, Eyeglass Lenses, Lenses, Eye Diagnosis & Surgery Instruments, Optical Components, Intraocular Lenses.
Who are the key members and board of directors at Contacare Opthalmic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagrat Dave  | Director | 25-Jul-2000 | Current |
| Purnima Dave | Director | 19-Nov-2009 | Current |
Financial Performance and Corporate Structure Insights of Contacare Opthalmic.
Contacare Opthalmic Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.52% decrease. The company also saw a substantial improvement in profitability, with a 52.49% increase in profit. The company's net worth dipped by a decrease of 6.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Contacare Opthalmic?
In 2023, Contacare Opthalmic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Care4sight Pharma Private LimitedActive 5 years 1 monthJagrat Dave and Purnima Dave are mutual person
- Caregroup Sight Solution Private LimitedActive 4 years 11 months
Jagrat Dave and Purnima Dave are mutual person
- Intra Ocular Care Private LimitedActive 35 years 14 days
Jagrat Dave and Purnima Dave are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2019 | ₹15.00 Cr | Satisfied |
Others Creation Date: 22 Aug 2017 | ₹35.00 Cr | Satisfied |
How Many Employees Work at Contacare Opthalmic?
Contacare Opthalmic has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Contacare Opthalmic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Contacare Opthalmic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
